GPX1 Pro198Leu — Your Selenium-Powered Antioxidant Shield
Glutathione peroxidase 1 (GPX1) is the most abundant member of the
selenoprotein family | Proteins that incorporate the amino acid selenocysteine at their active site, requiring dietary selenium for synthesis,
a group of enzymes that depend on dietary selenium for their activity. GPX1
serves as a frontline defense against oxidative damage by converting hydrogen
peroxide (H2O2) and organic hydroperoxides into harmless water and alcohols,
using glutathione | A tripeptide (glutamate-cysteine-glycine) that serves as the cell's primary antioxidant and detoxification molecule
as its reducing substrate. The Pro198Leu variant (rs1050450) changes a proline
to leucine in the enzyme, reducing its catalytic activity and -- critically --
diminishing its responsiveness to selenium. This makes it one of the most
actionable variants in the antioxidant pathway: adequate selenium intake can
partially compensate for the genetic reduction.
The Mechanism
GPX1 contains a
selenocysteine residue | The 21st amino acid, encoded by a UGA codon that is recoded by a selenocysteine insertion sequence (SECIS) in the mRNA's 3' UTR
at its active site, which is essential for catalysis. The enzyme reduces H2O2 to
water in a two-step reaction: selenocysteine is first oxidized by the peroxide
substrate, then reduced back to its active form by two molecules of glutathione.
This cycle occurs millions of times per second in every cell.
The Pro198Leu substitution (C>T at codon 198, reported as G>A on the plus strand)
does not directly disrupt the active site but alters the enzyme's tertiary
structure in a way that reduces catalytic efficiency.
In vitro studies | Hu YJ and Diamond AM demonstrated in breast carcinoma cell lines that the Leu variant shows significantly lower enzyme activity and reduced responsiveness to selenium supplementation
in cell lines showed the Leu allele produces an enzyme with approximately 40%
lower activity than the Pro allele. Perhaps more importantly, the Leu variant
shows a blunted response to selenium supplementation -- the enzyme fails to
upregulate as effectively when selenium levels rise.
A study of 405 healthy individuals | Jablonska E et al. Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans. Eur J Nutr, 2009
quantified this genotype-selenium interaction precisely. The correlation between
plasma selenium and red blood cell GPx1 activity was strong for Pro/Pro carriers
(r = 0.44, p < 0.001), intermediate for Pro/Leu (r = 0.35, p < 0.001), and
essentially absent for Leu/Leu (r = 0.25, p = 0.45). In other words, Leu/Leu
carriers derive substantially less antioxidant benefit from a given selenium
intake compared to Pro/Pro carriers.
The Evidence
The clinical consequences of reduced GPX1 activity have been examined across
multiple disease domains.
Cancer risk. A
comprehensive meta-analysis of 60 studies | Xie Y et al. Association between GPX1 rs1050450 polymorphisms and cancer risk. Int J Clin Exp Pathol, 2020
(21,296 cancer cases, 30,346 controls) found the TT (Leu/Leu) genotype
associated with modestly increased overall cancer susceptibility (OR 1.15,
95% CI 1.00-1.31). Subgroup analyses revealed particularly strong associations
with bladder cancer (OR 3.56, 95% CI 1.42-8.94), head and neck cancer
(OR 2.19, 95% CI 1.39-3.46), and brain tumors (OR 1.19, 95% CI 1.03-1.37).
Cardiovascular disease. A
meta-analysis of 10 studies | Bao Y et al. Association of GPx-1 rs1050450 Pro198Leu and Pro197Leu polymorphisms with cardiovascular risk. J Geriatr Cardiol, 2014
(1,430 cases, 3,767 controls) found the variant associated with cardiovascular
disease risk under a co-dominant model (OR 1.36, 95% CI 1.08-1.70), with a
particularly strong effect in East Asian populations (OR 1.84, 95% CI 1.39-2.43).
A Japanese study of type 2 diabetic patients found the Leu allele associated with
increased carotid intima-media thickness | Hamanishi T et al. Functional variants in GPx-1 gene associated with increased intima-media thickness and macrovascular disease in Japanese type 2 diabetic patients. Diabetes, 2004,
a marker of subclinical atherosclerosis.
Diabetic neuropathy. The TT genotype was significantly associated with
diabetic peripheral neuropathy | Tang TS et al. Pro198Leu polymorphism in GPX1 contributes to diabetic peripheral neuropathy in type 2 diabetes patients. NeuroMolecular Medicine, 2016
in type 2 diabetes patients (OR 1.89, 95% CI 1.30-2.74), likely through
increased oxidative damage to peripheral nerves.
Practical Implications
GPX1 Pro198Leu is unusually actionable because the enzyme's activity is
directly dependent on selenium availability. The
recommended dietary allowance (RDA) | 55 mcg/day for adults, set by the US Institute of Medicine based on the amount needed to maximize plasma GPx activity
for selenium is 55 mcg per day, but this was calibrated for an average
population. Individuals with the Leu allele likely need higher selenium
intake to achieve the same level of GPX1 activity. Good dietary sources
include Brazil nuts (one nut contains roughly 70-90 mcg selenium), seafood,
organ meats, and whole grains.
Selenium supplementation in the range of 100-200 mcg/day (total from diet
plus supplements) appears safe and may partially compensate for the genetic
reduction in enzyme activity. The tolerable upper limit is 400 mcg/day;
exceeding this risks selenosis (hair loss, nail changes, neurological
symptoms). Selenomethionine is the preferred supplemental form due to
superior bioavailability.
Beyond selenium, maintaining adequate glutathione levels supports GPX1
function. N-acetylcysteine (NAC), a glutathione precursor, and dietary
sources rich in cysteine (cruciferous vegetables, allium family) help
sustain the glutathione pool that GPX1 requires as its co-substrate.
Interactions
GPX1 functions in a critical two-step antioxidant relay with
SOD2 | Superoxide dismutase 2 (rs4880), the mitochondrial enzyme that converts superoxide radicals to hydrogen peroxide
(manganese superoxide dismutase, rs4880). SOD2 converts superoxide radicals
into hydrogen peroxide, which GPX1 then neutralizes to water. When GPX1
activity is reduced by the Pro198Leu variant, hydrogen peroxide generated
by SOD2 accumulates, increasing oxidative damage. This effect is compounded
when SOD2 itself carries the Val16Ala variant (rs4880 T allele), which
alters its mitochondrial import efficiency. Studies have shown that the
combination of variant alleles in both SOD2 and GPX1 is associated with
significantly higher oxidative stress markers and increased bladder cancer
risk compared to either variant alone. This SOD2-GPX1 interaction represents
a biologically plausible compound effect: SOD2 feeds H2O2 into GPX1, so
deficiency at either step -- or both -- disrupts the entire antioxidant
relay. A compound implication should be created for the combination of
GPX1 rs1050450 AA (or AG) with SOD2 rs4880 TT, recommending enhanced
antioxidant support including selenium, CoQ10, and mitochondria-targeted
antioxidants like MitoQ.
All genotypes
Normal GPX1 enzyme activity with full selenium responsiveness
You carry two copies of the Pro (proline) allele, which produces GPX1 enzyme with full catalytic activity. Your enzyme responds normally to dietary selenium, meaning standard selenium intake is sufficient to maintain optimal antioxidant defense. About 49% of people globally share this genotype, though it is more common in East Asian populations (approximately 88%) and less common among those of European descent (approximately 48%).
Moderately reduced GPX1 activity with blunted selenium response
You carry one Pro allele and one Leu allele, producing a mixture of normal and reduced-activity GPX1 enzyme. Your overall GPX1 activity is moderately lower than the GG genotype, and the enzyme's ability to upregulate in response to selenium is partially blunted. This is the most common genotype worldwide, shared by about 42% of the global population. The modest reduction in antioxidant capacity is compensated by ensuring adequate selenium intake.
Significantly reduced GPX1 activity (~40% lower) with poor selenium responsiveness
You carry two copies of the Leu allele, producing GPX1 enzyme with approximately 40% lower catalytic activity than the common variant. Critically, your enzyme responds poorly to increases in dietary selenium -- higher selenium intake helps less than it does for other genotypes. About 9% of people globally carry this genotype. This reduction in your primary hydrogen peroxide defense enzyme means you may benefit from proactive antioxidant support and selenium optimization.